Article Text

Download PDFPDF
CASE REPORT
Post-transfusion purpura: a rare and life-threatening aetiology of thrombocytopenia
  1. Parikshit Padhi1,
  2. Gulam Sadiq Parihar1,
  3. Jason Stepp2,
  4. Robert Kaplan3
  1. 1Department of Internal Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA
  2. 2Department of Hematology/Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA
  3. 3Department of Hematology/Oncology, West Penn Allegheny Health System, Pittsburgh, Pennsylvania, USA
  1. Correspondence to Dr Parikshit Padhi, parikshit.padhi{at}gmail.com

Summary

We present a middle-aged man with history of lung adenocarcinoma, who was admitted with massive haemoptysis secondary to severe thrombocytopenia. Two weeks prior he was started on enoxaparin for a newly diagnosed pulmonary embolus and at that time required blood transfusions for anaemia. Our initial diagnosis was heparin-induced thrombocytopenia. His platelet count, however, did not improve despite receiving argatroban and platelet transfusions. Hence, we suspected post-transfusion purpura (PTP) and started him on intravenous immunoglobulin which brought his platelet count to normal levels. The serotonin-release assay was negative and platelet-antibody test was positive confirming PTP as our diagnosis. The patient eventually was transferred to hospice care because of the advanced stage lung cancer and died of respiratory failure.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.